Additional Proxy Soliciting Materials (definitive) (defa14a)
April 01 2020 - 4:22PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934
Filed by the
Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐
|
Preliminary Proxy Statement
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
|
☐
|
Definitive Proxy Statement
|
☒
|
Definitive Additional Materials
|
☐
|
Soliciting Material Pursuant to § 240.14a-12
|
Seattle Genetics, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box)
|
|
|
|
|
|
|
☒
|
|
No fee required.
|
|
|
☐
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
|
|
|
|
Title of each class of securities to which transaction applies:
|
|
|
|
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing
fee is calculated and state how it was determined):
|
|
|
|
|
Proposed maximum aggregate value of transaction:
|
|
|
|
|
Total fee paid:
|
|
|
☐
|
|
Fee paid previously with preliminary materials.
|
|
|
☐
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing:
|
|
|
|
|
|
|
|
Amount Previously Paid:
|
|
|
|
|
Form, Schedule or Registration Statement No:
|
|
|
|
|
Filing Party:
|
|
|
|
|
Date Filed:
|
Online Go to www.envisionreports.com/SGEN or scan the QR code
— login details are located in the shaded bar below. Votes submitted electronically must be received by 11:59 PM, Eastern Time, on May 14, 2020. Shareholder Meeting Notice Important Notice Regarding the Availability of Proxy Materials
for the Seattle Genetics, Inc. Annual Shareholders Meeting to be Held on May 15, 2020 Under Securities and Exchange Commission rules, you are receiving this notice that the proxy materials for the annual shareholders meeting are available on the
Internet. Follow the instructions below to view the materials and vote online or request a copy. The items to be voted on and location of the annual meeting are on the reverse side. Your vote is important! This communication presents only an
overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting. The proxy statement and annual
report to shareholders are available at: www.envisionreports.com/SGEN Easy Online Access — View your proxy materials and vote. Step 1: Go to www.envisionreports.com/SGEN Step 2: Click on Cast Your Vote or Request Materials. Step 3:
Follow the instructions on the screen to log in. Step 4: Make your selections as instructed on each screen for your delivery preferences. Step 5: Vote your shares. When you go online, you can also help the environment by consenting to
receive electronic delivery of future materials. Obtaining a Copy of the Proxy Materials – If you want to receive a copy of the proxy materials, you must request one. There is no charge to you for requesting a copy. Please make your request as
instructed on the reverse side on or before May 3, 2020 to facilitate timely delivery.
Shareholder Meeting Notice Seattle Genetics, Inc. Annual Meeting of
Shareholders will be held on Friday, May 15, 2020 at 11:00 a.m. Pacific Time. Proposals to be voted on at the meeting are listed below along with the Board of Directors’ recommendations. The Board of Directors recommend a vote FOR all the
nominees named for director and a vote FOR Proposals 2, 3 and 4. 1. Election of Class I Directors: 01 - David W. Gryska 02 - John A. Orwin 03 - Alpna H. Seth 2. Approve, on an advisory basis, the compensation of Seattle Genetics’ named
executive officers as disclosed in the accompanying proxy statement. 3. Approve the amendment and restatement of the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan to, among other things, increase the aggregate number of
shares of common stock authorized for issuance thereunder by 6,000,000 shares. 4. Ratify the appointment of PricewaterhouseCoopers LLP as Seattle Genetics’ independent registered public accounting firm for the fiscal year ending December
31, 2020. PLEASE NOTE – YOU CANNOT VOTE BY RETURNING THIS NOTICE. To vote your shares you must go online or request a paper copy of the proxy materials to receive a proxy card. If you wish to attend and vote at the meeting, please bring this
notice with you. Directions to the meeting location can be found at www.seattlegenetics.com.
Seagen (NASDAQ:SGEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Seagen (NASDAQ:SGEN)
Historical Stock Chart
From Sep 2023 to Sep 2024